Call for Govt to help our neighbours negotiate for life-saving medicines


Trade talks for the proposed Regional Comprehensive Economic Partnership (RCEP) continue this week in China.

The trade deal includes a chapter on intellectual property that health organisations say could threaten countries’ access to life-saving medicines. Continue reading

Posted in Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment


The organisation T1International is calling for insulin and other vital diabetes supplies to be made available for everyone with diabetes through their Type 1 Diabetes Access Charter.

Around the globe today, millions of people with type 1 diabetes are dying because they cannot afford or get a hold of insulin, supplies, education and treatment. Continue reading

Posted in Uncategorized | Leave a comment

India to US: Will not tighten IPR rules beyond TRIPS mandate

Commerce Minister Nirmala Sitharaman demands food safety clearance mechanism during talks with US Trade Representative

Source: The Hindu BusinessLine | October 20, 2016

India and the US continued to differ on the issue of intellectual property rights (IPR) norms at the bilateral Trade Policy Forum meeting on Thursday.

While Commerce and Industry Minister Nirmala Sitharaman cited a UN report to “vindicate’’ the country’s stand on not going beyond the commitments made in the global TRIPS Agreement, US Trade Representative (USTR) Michael Froman said that he was looking forward to India developing new laws and policies. Continue reading

Posted in Compulsory Licensing, Data Exclusivity, Evergreening, IPR, Patent linkage, Sec 3 (d), TRIPS, TRIPS plus, Uncategorized, UNHLP report, USTR 301 report | Leave a comment

Our view on India and US Joint Statement on the Trade Policy Forum Delhi – October 20, 2016

In the recently concluded US India Trade Policy Forum meeting held in Delhi, both countries laid emphasis on the importance of having a robust and balanced IPR protection in fostering creativity, promoting innovation, and attracting investment. Indian government was praised for drafting National IPR policy, reducing patent application pendency and simplifying patent procedures.

Indian Commerce Minister mentioned that IPR Policy is being implemented through various actionable points to foster creativity and innovation in the country.

Our View: Greater emphasis on linkage of IPR with innovation can be very problematic from the point of access to affordable medicines and has been proven globally by health activists and academicians. The emphasis on simplifying and speeding patent application process can result in grant of frivolous patents that lead to patent ever greening.

Continue reading

Posted in IPR, IPR policy, TRIPS plus, Uncategorized | Leave a comment

RCEP patent clauses lack compassion says Public Health Association

Public Health Association media release 21 October 2016

The Public Health Association of New Zealand (PHA) is calling on New Zealand Government negotiators to oppose clauses in the Regional Comprehensive Economic Partnership (RCEP), currently being negotiated, that would increase the cost of life-saving medicines in poorer countries. Continue reading

Posted in Data Exclusivity, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment

UN High Level Panel report is good prescription for change in access to medicines

Source: PharmaLetter | October 18, 2016

In our weekly expert view piece, Rohit Malpani, director of policy and analysis for Mèdecins Sans Frontiéres Access Campaign, discusses the UN Secretary General’s High-Level Panel report on Access to Medicines and looks at the responsibilities it places on industry.

During the UN General Assembly in New York last month, the UN Secretary General’s High-Level Panel on Access to Medicines released its much-anticipated report, containing recommendations for governments and the pharmaceutical industry on how to enable better access to medicines and vaccines and how to ensure medical research and development (R&D) addresses unmet priority health needs. Continue reading

Posted in Delinkage, R&D, TPP, TRIPS, TRIPS flexibilities, TRIPS plus, Uncategorized | Leave a comment

Kerala govt opposes RCEP agreement

Source: PTI | October 18, 2016

Kerala government has opposed Centre’s move to sign the Regional Comprehensive Economic Partnership (RCEP) agreement, saying it would further worsen the crisis in the state’s cash crops sector.

Continue reading

Posted in Uncategorized | Leave a comment